CymaBay Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on CymaBay Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how CymaBay Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with CymaBay Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on CymaBay Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 11 Sep 2023 | CymaBay Therapeutics Raises USD258.70 Million in Public Offering of Shares | Equity Offering | - |
CymaBay Therapeutics Inc |
| 23 Jan 2023 | CymaBay Therapeutics Raises USD97.74 Million in Public Offering of Shares | Equity Offering | - |
CymaBay Therapeutics Inc |
| 08 Jan 2023 | Kaken Pharma Enters into Licensing Agreement with CymaBay Therapeutics | Licensing Agreement |
Kaken Pharmaceutical Co Ltd
|
CymaBay Therapeutics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer